The global breast imaging market is estimated to be valued at USD 4.46 Bn in 2024 and is expected to exhibit a CAGR of 7.9% during the forecast period (2024-2031). Breast imaging refers to medical imaging techniques used to visually examine the breast in order to screen for or diagnose abnormalities. It allows the detection of breast abnormalities at an early stage, which improves survival rates of breast cancer patients. Key technologies, such as mammography, breast ultrasound, breast magnetic resonance imaging, and others, have advanced significantly in terms of accuracy and affordability. Rising awareness regarding early diagnosis and screening is driving more women across age groups to undergo annual breast imaging tests. Furthermore, continued technological innovations and growing health expenditure are also expected to propel the breast imaging market growth in the coming years.

Market Dynamics:

The global breast imaging market is primarily driven by increasing incidence of breast cancer, rising awareness about early diagnosis, and technological advancements. According to World Health Organization, breast cancer is the most common cancer in women worldwide, with an estimated 2.3 million new cases diagnosed in 2020. Early diagnosis is critical for successful breast cancer treatment. Growing awareness initiatives by governments and NGOs has increased screening rates globally. Additionally, ongoing R&D has led to development of innovative breast imaging modalities like 3D mammography, offering improved lesion detection. However, risks of radiation exposure from breast screening procedures and strict regulatory approval process for new breast imaging devices pose challenges. Nevertheless, untapped emerging markets offer lucrative opportunities for players to further expand the customer reach.

Key Features of the Study:

• This report provides an in-depth analysis of the global breast imaging market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global breast imaging market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, and PLANMED OY
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global breast imaging market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global breast imaging market.

Detailed Segmentation-

• By Technology:
  • Ionizing Breast Imaging
    • Mammography
    • Positron Emission Tomography-Computed Tomography (PET-CT)
    • Molecular Breast Imaging (MBI)
  • Non-ionizing Breast Imaging
    • Ultrasound
    • MRI
    • Image-guided breast biopsy
  • Others
• By End User:
  • Hospitals
  • Diagnostic Centers
  • Others (Specialty Clinics, Ambulatory Surgical Centers, etc.)
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• GE Healthcare
• Siemens Healthcare GmbH
• Seno Medical
• Koninklijke Philips N.V.
• Fujifilm Holdings Corporation
• Hologic, Inc.
• Aurora Imaging Technologies, Inc.
• Canon Inc.
• Dilon Technologies, Inc.
• Leica Biosystems Nussloch GmbH (Danaher)
• Carestream Health
• Avante Health Solutions
• Hitachi, Ltd
• PLANMED OY